Backed by a handful of prominent investors including the Gates Foundation, the startup is pursuing an approach it believes ...

Minaris will move its center for viral vector innovation to occupy space within CGT Catapult's collaborator laboratories in London and will work with CGT Catapult on the further development of ...

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within ...

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.

A long-term, trust-based CDMO partnership can support cell and gene therapy developers from early process development through ...

A 10-month-old baby who sparked nationwide headlines after receiving a first-of-its kind gene-editing treatment was released ...

To reset the laboratory space to an operational environment, TOMI’s iHP Corporate Service team will perform a comprehensive whole-facility fogging service. This service covers all critical areas, ...

The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas. KJ Muldoon is walking and getting ready to celebrate ...

Tomi Environmental Solutions (TOMZ) announced that a cell and gene therapy manufacturer has adopted SteraMist ionized hydrogen peroxide technology ...

Later-stage financing deals for cell and gene therapy companies reflects a broader derisking trend in the pharma industry.

The search for gene therapies to treat rheumatoid arthritis (RA) has moved in fits and starts over the past two decades, with trials starting and stopping, and their focus shifting to osteoarthritis ...

The MarketWatch News Department was not involved in the creation of this content. EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent ...